Document:

Exhibit 10.7

 

Letter of appointment of Independent
Director

 

Date __ 2018

 

Mr. ___________________

 

A hearty welcome to WECONNECT TECH INTERNATIONAL INC.,
as Independent Director of the Board of our Company.

 

We are pleased to confirm your appointment as Non-Executive-Independent
Director on the Board of Directors of WECONNECT TECH INTERNATIONAL INC. as (WECT) (hereinafter referred to as WECT
or the Company) with effect from ____________.

 

This letter of appointment sets out the terms and conditions
covering your appointment which are as follows:

 

		1.	Appointment

 

Your term of appointment as Non-Executive Independent Director
on the Board of Directors of WECT with effect from 1st June 2018.

 

		2.	Committees

 

The Board of Directors (the Board) may, if it deems fit, invite
you for being appointed on one or more existing Board Committees or any such Committee that is set up in the future. Your appointment
on such Committee(s) will be subject to the applicable laws and regulations.

 

By accepting this appointment, you confirm that you can allocate
sufficient time to meet the expectations from your role to the satisfaction of the Board.

 

3. Role and Duties

 

As a member of the board, your role, duties and responsibilities
will be those normally required of a Non-Executive Independent Director under the required Act and regulations.

 

		(1)	A director of a company shall always exercise his powers in accordance with the Act, for a proper purpose and in good faith
in the best interest of the company.

 

		(2)	A director of a company shall exercise reasonable care, skill and diligence with—

 

		a.	the knowledge, skill and experience which may reasonably be expected of a director having the same
responsibilities; and

 

		b.	any additional knowledge, skill and experience which the director in fact has.

 

		(3)	A director who contravenes this section commits an offence and shall, on conviction, be liable
to imprisonment for a term not exceeding five years or to a fine not exceeding three million Malaysian Ringgit or to both.

 

 

 

 

    	 	1	 

     

    

 

4. Remuneration, etc.

Fee:

 

You will be paid such remuneration by way of sitting fees for
meetings of the Board and its Committees as may be decided by the Board and/or approved by the Shareholders from time to time.

 

The sitting fees presently paid to the Non-Executive Independent
Director is USD _____ (US Dollar __________ Only) per month.

 

5. Code of Conduct & other compliances

 

During the appointment, you will comply with any relevant regulations
as may be issued by the relevant authorities, including the Code for Independent Directors, Code of Conduct and Ethics for Directors
and Senior Executives and Insider Trading Code and such other requirements as the Board of Directors may from time to time specify.

 

6. Conflict of Interest

 

It is accepted and acknowledged that you may have business
interests other than those of the Company. As a condition of your appointment commencing, you are required to declare any such
directorships, appointments and interests to the Board in writing in the prescribed format the time of your appointment.

 

If your circumstances seem likely to change and might give
rise to a conflict of interest or, when applicable, circumstances that might lead the Board to revise its judgement that you are
independent, this should be disclosed to both the Chairman and the Secretary.

 

7. Confidentiality

 

All information acquired during your appointment is confidential
to WECT and should not be released, either during your appointment or following termination (by whatever means) to third
parties without prior clearance from the Chairman unless required by law or by the rules of any stock exchange or regulatory body.
On reasonable request, you shall surrender any documents and other materials made available to you by WECT.

 

Your attention is also drawn to the requirements under the
applicable regulations and the WECT Share Dealing Code which concerns the disclosure of price sensitive information and
dealing in the securities of WECT. Consequently, you should avoid making any statements or performing any transactions
that might risk a breach of these requirements without prior clearance from the Chairman or the Secretary.

 

8. Evaluation

 

The Company will carry out an evaluation of the performance
of the Board as a whole, Board Committees and Directors. Your appointment and reappointment on the Board shall be subject to the
outcome of the evaluation process.

 

9. Disclosure of Interest

 

You shall disclose material interest that in any transaction
or arrangement that the Company has entered. Such interest should be disclosed no later than when the transaction or arrangement
comes up at a Board meeting so that the minutes may record your interest appropriately and our records are updated. A general
notice that you are interested in any contracts with a person, firm or company is acceptable.

 

 

 

    	 	2	 

     

    

 

10. Termination

 

a. You may resign from your
position at any time and should you wish to do so, you are requested to serve a reasonable written notice on the Board.

 

b. Continuation of your appointment is contingent on your getting
re-elected by the shareholders in accordance with provisions of relevant ACT, and the Articles of Association of the The company,
from time to time in force. You will not be entitled to compensation if the shareholders do not re-elect you at any time.

 

c. Your appointment may also be terminated in accordance with
the provisions of the Articles of Association of the Company from time to time in force.

 

Yours sincerely,

 

 

 

 

___________________________________

CEO, Director

 

For and on behalf of WECONNECT TECH INTERNATIONAL INC

 

____________________________________________________________________________

 

AGREED AND ACCEPTED

 

I have read and understood the terms of my appointment as an
Independent Director of the Company and I hereby affirm my acceptance to the same.

 

 

___________________________________

Name:

Date:

 

 

 

    	 	3EX-4.2

 Exhibit 4.2 
  

 
 ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS# COMMON STOCK COMMON STOCK PAR VALUE $0.0001 Certificate
Shares Number 000000 000000 ZQ00000000 000000 XERIS PHARMACEUTICALS, INC. 000000 000000 INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample
Mr. Alexander David Sample SEE REVERSE FOR CERTAIN DEFINITIONS Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David THIS CERTIFIES THAT Sample Mr. Alexander David Sample Mr.
Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr MR . Alexander. David SAMPLE Sample Mr. Alexander David & Sample MRS Mr. Alexander . SAMPLE David Sample Mr. Alexander & David Sample
Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr Alexander David Sample Mr. Alexander David Sample CUSIP 98422L 10 7 Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander
David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander MR David Sample . SAMPLE Mr. Alexander David Sample & Mr
.. Alexander MRS David Sample . SAMPLE Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David
Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Alexander David Sample Mr. Sample Mr. Sample is the owner of 000000 Shares
000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000
Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 0 THIS CERTIFICATE IS TRANSFERABLE IN 00000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 00 ZERO HUNDRED
THOUSAND 0000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000 CITIES DESIGNATED BY THE TRANSFER 000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000
Shares 000000 Shares 0000 AGENT, AVAILABLE ONLINE AT 00 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 00000 0 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares
000000 Shares 000000 Shares 000000 ZERO HUNDRED AND ZERO www.computershare.com Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000
Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000 Shares 000000S FULLY-PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF Xeris Pharmaceuticals,
Inc. (hereinafter called the “Company”), transferable on the books of the Company in person or by duly authorized attorney, upon surrender of this Certificate properly endorsed. This Certificate and the shares represented hereby, are
issued and shall be held subject to all of the provisions of the Certificate of Incorporation, as amended, and the By-Laws, as amended, of the Company (copies of which are on file with the Company and with the Transfer Agent), to all of which each
holder, by acceptance hereof, assents. This Certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar. Witness the facsimile seal of the Company and the facsimile signatures of its duly authorized officers.
DATED DD-MMM-YYYY ACEU M T COUNTERSIGNED AND REGISTERED: FACSIMILE SIGNATURE TO COME R I A PO C H R RA P CO T A COMPUTERSHARE TRUST COMPANY, N.A. E L I N D S President S , TRANSFER AGENT AND REGISTRAR, R I I N E C X . July 29, 2005 DEL RE FACSIMILE
SIGNATURE TO COME AWA By Secretary AUTHORIZED SIGNATURE CUSIP/IDENTIFIER XXXXXX XX X Holder ID XXXXXXXXXX Xeris Pharmaceuticals, Inc. Insurance Value 1,000,000.00 Number of Shares 123456 DTC 12345678 123456789012345 PO BOX 43004, Providence, RI
02940-3004 Certificate Numbers Num/No. Denom. Total MR A SAMPLE 1234567890/1234567890 1 1 1 DESIGNATION (IF ANY) 1234567890/1234567890 2 2 2 ADD 1 ADD 2 1234567890/1234567890 3 3 3 1234567890/1234567890 4 4 4 ADD 3 ADD 4 1234567890/1234567890 5 5 5
1234567890/1234567890 6 6 6 Total Transaction 7 

 

 
 The IRS requires that the named transfer agent (“we”) report the costbasis of certain shares or units acquired after January
1, 2011. If yourshares or units are covered by the legislation, and you requested to sellor transfer the shares or units using a specific cost basis calculationmethod, then we have processed as you requested. If you did notspecify a cost basis
calculation method, then we have defaulted to thefirst in, first out (FIFO) method. Please consult your tax advisor if youneed additional information about cost basis.If you do not keep in contact with the issuer or do not have anyactivity in your
account for the time period specified by state law,your property may become subject to state unclaimed propertylaws and transferred to the appropriate state.For value received, hereby sell, assign and transfer untoShares AttorneyDated: 20Signature:
Signature: Notice: The signature to this assignment must correspond with the nameas written upon the face of the certificate, in every particular,without alteration or enlargement, or any change whatever.PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE)of the common stock represented by the within Certificate, and do hereby irrevocably constitute and appointto transfer the said stock
on the books of the within-named Company with full power of substitution in the premises..XERIS PHARMACEUTICALS, INC.THE COMPANY WILL FURNISH WITHOUT CHARGE TO EACH SHAREHOLDER WHO SO REQUESTS, A SUMMARY OF THE POWERS, DESIGNATIONS,PREFERENCES AND
RELATIVE, PARTICIPATING, OPTIONAL OR OTHER SPECIAL RIGHTS OF EACH CLASS OF STOCK OF THE COMPANY AND THEQUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES AND RIGHTS, AND THE VARIATIONS IN RIGHTS, PREFERENCES ANDLIMITATIONS DETERMINED
FOR EACH SERIES, WHICH ARE FIXED BY THE CERTIFICATE OF INCORPORATION OF THE COMPANY, AS AMENDED, ANDTHE RESOLUTIONS OF THE BOARD OF DIRECTORS OF THE COMPANY, AND THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINEVARIATIONS FOR FUTURE SERIES. SUCH
REQUEST MAY BE MADE TO THE OFFICE OF THE SECRETARY OF THE COMPANY OR TO THE TRANSFERAGENT. THE BOARD OF DIRECTORS MAY REQUIRE THE OWNER OF A LOST OR DESTROYED STOCK CERTIFICATE, OR HIS LEGALREPRESENTATIVES, TO GIVE THE COMPANY A BOND TO INDEMNIFY IT
AND ITS TRANSFER AGENTS AND REGISTRARS AGAINST ANY CLAIM THATMAY BE MADE AGAINST THEM ON ACCOUNT OF THE ALLEGED LOSS OR DESTRUCTION OF ANY SUCH CERTIFICATE.Signature(s) Guaranteed: Medallion Guarantee StampTHE SIGNATURE(S) SHOULD BE GUARANTEED BY AN
ELIGIBLE GUARANTOR INSTITUTION (Banks,Stockbrokers, Savings and Loan Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVEDSIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15.The following abbreviations, when used in the
inscription on the face of this certificate, shall be construed as though they were written out in fullaccording to applicable laws or regulations:TEN COM - as tenants in common UNIF GIFT MIN ACT - Custodian (Cust) (Minor)TEN ENT - as tenants by the
entireties under Uniform Gifts to Minors Act (State)JT TEN - as joint tenants with right of survivorship UNIF TRF MIN ACT - Custodian (until age)and not as tenants in common (Cust) under Uniform Transfers to Minors Act (Minor) (State)Additional
abbreviations may also be used though not in the above list.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]